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Abstract
Study Objective: To identify characteristics associated with provider attitudes on the safety of 
‘Quick Start’ initiation of long-acting reversible contraception (LARC) for adolescents.
Study Design, Setting, and Participants: We conducted a cross-sectional survey of 
providers in public-sector health centers and office-based physicians (n = 2,056) during 2013–
2014.
Results: Overall, the prevalence of considering ‘Quick Start’ initiation of LARC for adolescents 
as safe was 70.9% for implants and 64.5% for intrauterine devices (IUDs). Among public-sector 
providers, those not trained in implant or IUD insertion had lower odds of perceiving the practice 
safe (aOR 0.32 95% CI 0.25–0.41 for implants; aOR 0.42 95% CI 0.32–0.55 for IUDs), whereas 
those practicing at health centers that did not receive Title X funding had lower odds of perceiving 
the practice safe for IUDs (aOR 0.77 95% CI 0.61–0.98). Among office-based physicians, lack of 
training in LARC insertion was associated with lower odds of perceiving ‘Quick Start’ initiation to 
be safe for IUDs (aOR 0.31 95% CI 0.12–0.77). Those specializing in adolescent medicine had 
higher odds of reporting ‘Quick Start’ initiation of LARC as safe (implants, aOR 2.21 95% CI 
1.23–3.98; IUDs, aOR 3.37 95%CI 1.39–8.21) compared with obstetrician-gynecologists.
Conclusions: Approximately two-thirds of providers considered ‘Quick Start’ initiation of 
LARC for adolescents safe; however, there were differences by provider characteristics (e.g., Title 
X funding, training in LARC insertion, specialty). Targeted LARC insertion training and 
dissemination of evidence-based family planning guidance and implementation into facility and 
practice-level policies may increase access to ‘Quick Start’ initiation of LARC for adolescents.
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Introduction
During 2011–2013, national estimates of long-acting reversible contraception use (i.e., 
LARC: intrauterine device [IUD], including levonorgestrel IUD [LNG-IUD] and copper 
IUD [Cu-IUD]; and contraceptive implant) among female adolescents aged 15–19 years 
were lower (3.2%), compared with young adults (20–24 years, 11.1%) at risk for unintended 
pregnancy.1 During 2011–2015, 5.8% of female adolescents aged 15–19 years who had ever 
had sexual intercourse had ever used LARC, with 2.8% having used the IUD and 3.0% 
having used implants.2 Lower rates of LARC use among adolescents may be attributed to 
high out-c), quality and content of contraceptive counseling, provider misconceptions about 
the appropriateness of LARC for adolescents, and lack of provider training on LARC 
insertion.3–6
‘Quick Start’ initiation of LARC is an important strategy to reduce barriers to access. ‘Quick 
Start,’ or same-day initiation, eliminates unnecessary repeat visits by allowing same-day 
initiation of contraception if the provider is reasonably certain that the patient is not 
pregnant.7 Some studies suggest that policies and practices supporting ‘Quick Start’ of 
LARC are related to increased provision of these methods.8–10 The US Selected Practice 
Recommendations for Contraceptive Use (US SPR) recommends that IUDs and implants 
can be initiated at any time in women who are medically eligible, if it is reasonably certain 
that the woman (or adolescent) is not pregnant.11 Most women can safely use IUDs and 
implants; there are few conditions for which LARC initiation is not recommended (e.g., 
women with current purulent cervicitis, pelvic inflammatory disease, chlamydial infection, 
or gonococcal infection should not initiate an IUD; women with breast cancer should not 
initiate implants or LNG IUDs).12 For women who have already been tested for sexually 
transmitted infection (STI) according to recommendations,13 no further testing is required, 
and if STI screening is needed, it can be performed at the time of IUD insertion, which 
should not be delayed.11 Further, ‘Quick Start’ initiation of LARC is supported by the 
American Academy of Pediatrics (AAP) and the American College of Obstetricians and 
Gynecologists (ACOG).14,15
Although ‘Quick Start’ of LARC in women who are medically eligible is safe, few providers 
offer same-day initiation of IUDs to clients.9,16 For adolescents, providers may have 
concerns about LARC safety,17–19 including concerns related to the risk of STIs.20 LARC 
methods are safe for adolescents,12 and ‘Quick Start’ may be important for adolescents who 
might be unable to attend or are deterred by multiple visits. Little is known about provider 
attitudes toward ‘Quick Start’ initiation of LARC among adolescents. Because provider 
knowledge of the safety of LARC and ‘Quick Start’ initiation of these methods for 
adolescents may influence LARC provision practices, knowing provider attitudes and 
practices related to contraception for adolescents is key, particularly those supported by 
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evidence-based family planning guidance. The purpose of this analysis was to determine 
family planning provider attitudes on the safety of ‘Quick Start’ initiation of LARC for 
adolescents. Further, we aimed to identify provider characteristics associated with reporting 
‘Quick Start’ initiation of implants and IUDs for adolescents as a safe practice.
Materials and Methods
We analyzed data from a health care provider survey designed to evaluate US family 
planning provider attitudes and practices related to the safety and provision of contraception 
for women with specific medical conditions or characteristics. We collected data for 12 
months using a 33-item questionnaire mailed during 2013–2014 to a random sample of 
2,000 office-based physicians and 4,000 public-sector health centers that provided family 
planning services (herein referred to as public-sector health centers). For each sampled 
public-sector health center, we asked that one provider complete the survey. We identified 
public-sector health centers from a Guttmacher Institute database of all publicly funded 
family planning centers nationwide,10 and office-based physicians from the American 
Medical Association (AMA) Masterfile containing information on AMA member and 
nonmember board-certified physicians.21 Providers were eligible to participate in the survey 
if they provided family planning services (i.e., any service related to postponing or 
preventing pregnancy) to women of reproductive age at least twice per week. The sampling 
design and survey methodology are described in detail elsewhere.22
To assess provider attitudes on the safety of ‘Quick Start’ initiation, we used responses to the 
following question, “For each of the following contraceptive methods, how safe do you think 
it is to start [an adolescent] woman on the day of her visit regardless of the timing of her 
menses (‘Quick Start’) if you are reasonably certain she is not pregnant?” Providers were 
asked to answer regarding the ‘contraceptive implant’ and ‘intrauterine devices (Cu-IUD or 
LNG-IUD)’ for adolescents. We dichotomized provider responses into two groups: those 
reporting ‘Quick Start’ as safe, and those not reporting ‘Quick Start’ as safe (i.e., unsafe or 
don’t know). After excluding respondents not providing services to adolescents (n = 4) and 
providers who did not respond to questions about attitudes on the safety of ‘Quick Start’ 
initiation of LARC for adolescents, our analytic sample consisted of 1,967 providers for 
implants and 1,939 providers for IUDs.
Statistical Analysis
Data were weighted to account for nonresponse and sample selection probabilities to 
generate nationally representative estimates. Weighted data were analyzed in Stata 14.0 
using the software’s survey functions to account for the complex sampling design. We 
estimated unweighted frequencies and weighted percentages of sample characteristics. We 
examined differences among provider perceptions of the safety of ‘Quick Start’ initiation of 
LARC for adolescents by sample characteristics using Rao Scott chi-square tests, 
appropriate to use when data are obtained from a complex survey. We then performed 
multivariable logistic regression to identify provider characteristics associated with 
considering ‘Quick Start’ initiation of LARC as safe for adolescents; models were run 
separately for public-sector providers and office-based physicians. Multivariable models 
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included covariates found to be statistically significant (0.05 alpha level) in bivariate 
analyses, in addition to variables selected a priori based on the literature (i.e., Title X 
funding and primary clinical focus for public-sector models; and region, provider gender, 
and proportion of female patients of reproductive age who receive family planning services 
for both public-sector and office-based physician models). For public-sector providers, 
primary clinical focus at the clinic was dichotomized as reproductive health (obstetrics/
gynecology or family planning/reproductive health) or primary care (family medicine, 
adolescent health or pediatrics, or general health care) based on survey responses. Region of 
practice was determined by the clinic mailing address. We categorized states according to 
the US Census Bureau regions and US Territories according to the Health and Human 
Services regions.23 Adjusted odds ratios (aORs) are reported with 95% confidence intervals 
(CIs). The CDC determined this project to be non-research, public health practice, and 
Institutional Review Board approval was not needed.
Results
Assuming that the proportion of eligible providers among those with unknown eligibility 
was the same as the proportion among those with known eligibility, our overall response rate 
was 51.2% (n = 2,087). Response rates varied by respondent type (66% for Title X funded 
clinics, 48% for non-Title X funded clinics, and 40% for office-based physicians).
Provider Characteristics
Table 1 presents sample characteristics among public-sector providers (n = 1,650) and 
office-based physicians (n = 406). Of public-sector providers, the majority practiced at 
health centers that receive Title X funding (52.5%), reported their primary clinical focus as 
reproductive health (54.8%), were advanced clinical practitioners (i.e., physician assistant, 
nurse practitioner, certified nurse midwife; 59.8%), and were trained in implant (50.9%) and 
IUD (62.6%) insertions. Most office-based physicians specialized in obstetrics and 
gynecology (60.6%), and were trained in implant (50.6%) and IUD (85.2%) insertions.
Overall, the prevalence of considering ‘Quick Start’ initiation of LARC for adolescents as 
safe was 70.9% for implants and 64.5% for IUDs (data not shown). Among public-sector 
providers, the prevalence of considering ‘Quick Start’ initiation of LARC for adolescents as 
safe was 66.2% for implants and 62.9% for IUDs. Among office-based physicians, 71.6% 
and 64.7% reported ‘Quick Start’ initiation of implants and IUDs safe, respectively.
Factors Associated with Considering ‘Quick Start’ Initiation of LARC as Safe for 
Adolescents Among Public-Sector Providers
Factors associated with provider attitudes on the safety of ‘Quick Start’ initiation of LARC 
for adolescents among public-sector providers are presented in Table 2. Providers who were 
not trained in LARC insertion had lower odds of reporting ‘Quick Start’ initiation of LARC 
as safe for adolescents, relative to trained providers (implants: aOR 0.32 95% CI 0.25–0.41; 
IUDs: aOR 0.42 95% CI 0.32–0.55). Relative to providers in Title X-funded clinics, those 
who practiced at health centers that did not receive Title X funding had lower odds of 
reporting ‘Quick Start’ initiation of IUDs as safe (aOR 0.77 95% CI 0.61–0.98), as did 
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providers who reported their primary clinical focus as primary care versus reproductive 
health (aOR 0.67 95% CI 0.52–0.85). Compared with physicians, nurses had lower odds of 
reporting ‘Quick Start’ initiation as safe for both implants (aOR 0.64 95% CI 0.43–0.96) and 
IUDs (aOR 0.63 95% CI 0.40–0.97). Having a moderate (25–49%) versus large (≥50%) 
proportion of female patients of reproductive age receiving family planning services was 
associated with lower odds of perceiving ‘Quick Start’ initiation of IUDs as safe (aOR 0.66 
95% CI 0.49–0.88).
Factors Associated with Considering ‘Quick Start’ Initiation of LARC as Safe for 
Adolescents Among Office-Based Physicians
Table 3 shows the factors associated with perceiving ‘Quick Start’ initiation of LARC as 
safe among office-based physicians. Compared with physicians who specialized in obstetrics 
and gynecology, providers who specialized in adolescent medicine had higher odds of 
reporting ‘Quick Start’ initiation of LARC as safe (implant: aOR 2.21 95% CI 1.23–3.98; 
IUD: 3.37 95% CI 1.39–8.21). In addition, providers not trained compared with those 
trained in IUD insertion had lower odds of reporting ‘Quick Start’ initiation of IUDs as safe 
for adolescents (aOR 0.31 95% CI 0.12–0.77). Compared with providers who had a large 
(≥50%) proportion of female patients of reproductive age receiving family planning services, 
providers with a small (1–24%) proportion had lower odds of perceiving ‘Quick Start’ 
initiation of implants as safe (aOR 0.44 95% CI 0.20–0.97).
Discussion
In our analysis, approximately two-thirds of providers considered ‘Quick Start’ initiation of 
LARC for adolescents as safe. Among both public-sector providers and office-based 
physicians there was variation in reporting ‘Quick Start’ of LARC for adolescents as safe by 
provider, practice, and clinic characteristics, which may indicate opportunities for targeted 
trainings or adaption of same-day initiation guidance into protocols.
Across provider groups, those not trained in implant or IUD insertion less frequently 
reported ‘Quick Start’ initiation of LARC for adolescents as safe. Hands-on clinical 
insertion training of implants and IUDs likely includes education about eligible candidates 
for LARC methods and when they can be safely initiated.24,25 For women starting LARC 
methods, the US SPR guidelines state that the benefits of starting at the time of the initial 
health care visit likely exceed any risks, and providers should consider starting a method at 
any time, when reasonably certain the patient is not pregnant.11 ACOG and AAP also 
support the safety of LARC for adolescents and recommend ‘Quick Start’ initiation for most 
adolescents.14,15 Nonetheless, despite existing evidence that receipt of didactic and insertion 
training is more commonly received among obstetrician-gynecologists than clinicians with 
other specialties (e.g., adolescent medicine, pediatrics, family medicine),26 we found 
obstetrician-gynecologists had lower odds of considering ‘Quick Start’ initiation of LARC 
as safe for adolescents compared with adolescent medicine providers. These data may 
suggest that although obstetrician-gynecologists are more often trained in LARC insertion, 
more specific training on the safety of ‘Quick Start’ initiation of LARC methods for 
adolescents may be needed. Offering LARC insertion training in medical residencies and 
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continuing education opportunities for practicing clinicians may improve provider LARC 
insertion competencies.
Public-sector providers who reported their primary clinical focus as primary care had lower 
odds of reporting ‘Quick Start’ initiation of IUD as safe for adolescents than those who 
reported reproductive health. These findings parallel data on the availability and provision of 
IUDs in publicly funded health centers, with reproductive health-focused clinics being more 
likely than primary care-focused clinics to provide IUDs to adolescents.10 Similarly, public-
sector providers that practiced in clinics that did not receive Title X funding had lower odds 
of reporting ‘Quick Start’ initiation of IUDs as safe, compared with providers who practiced 
in Title X-funded clinics; this difference was observed for attitudes on ‘Quick Start’ of 
implants for adolescents, but was not statistically significant. In a qualitative study of 
structural barriers to LARC provision at community health centers, no LARC providers 
reported that they routinely performed same-day insertions, often because of scheduling 
challenges, shorter appointment times, provider’s knowledge and comfort with contraceptive 
counseling, protocol to schedule pre-insertion counseling visits, and required STI testing 
before insertions, which may not be necessary.27 Further, provider-level variability in 
contraceptive counseling was influenced by the focus of the community health center, where 
providers at primary care-focused clinics addressed routine preventive care and disease 
management concerns in one visit.27 These findings may suggest challenges to providing 
family planning in the context of providing the breadth of primary care services. Developing 
and implementing targeted training and protocols for primary care clinics may address these 
challenges.
Among public-sector providers, nurses had the lowest frequency of considering ‘Quick 
Start’ initiation of LARC for adolescents as safe. As nurses constitute a large and critical 
part of the health care workforce who often provide contraceptive counseling, particularly in 
the public sector,28 training nurses on best practices in contraceptive counseling and family 
planning provision may increase awareness about the safety and effectiveness of LARC 
methods for adolescents and ‘Quick Start’ initiation. An intervention for integrating LARC 
counseling into routine contraceptive care showed a significant increase in LARC 
counseling, along with a significant increase in LARC uptake and a significant reduction in 
unintended pregnancy rates.29 Targeted efforts to disseminate family planning guidance11,12 
to provider groups and training all clinic staff on best contraceptive practices (including 
‘Quick Start’) may increase counseling on same-day initiation of LARC methods.
Overall, the majority of providers in our sample considered ‘Quick Start’ initiation of LARC 
safe for adolescents. Although these data are encouraging, facility and practice-level barriers 
may inhibit provision of LARC. In one study, facility policies permitting same-day LARC 
initiation were the most significant predictor of LARC placements by advanced practice 
registered nurses during the past year.8 In an analysis of survey data collected from 1,221 
fellows of the American College of Obstetricians and Gynecologists, only 13.1% of 
providers reported offering same-day IUD insertion, and those who offered same-day IUD 
insertion provided significantly more IUDs during the previous year than those who required 
multiple clinic visits.9 From a survey of generalist pediatricians in the Massachusetts 
Pediatric Society, 10.6% recommended IUD as a preferred choice of contraception for 
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adolescents.30 These data suggest that although providers may understand that LARC 
methods and ‘Quick Start’ initiation of these methods are safe for adolescents, providers 
may hesitate to counsel adolescents on LARC as a contraceptive option if they are restricted 
by practice policies, which may influence ‘Quick Start’ provision of LARC to adolescents.
A few limitations should be considered when interpreting our findings. Data were self-
reported and may be subject to social desirability bias. Second, the survey question that 
ascertained attitudes about the safety of ‘Quick Start’ of IUDs asked about IUDs generally; 
thus, we were unable to determine if providers had differential concerns for different IUD 
types (copper or hormonal). In addition, the survey question did not differentiate between 
nulliparous and parous adolescents; although IUDs are safe for all adolescents, regardless of 
parity,12 some providers may have concerns about the safety of IUDs for nulliparous 
adolescents. Finally, the survey did not collect data on ‘Quick Start’ provision of LARC to 
adolescents.
Despite these limitations, these data provide estimates of attitudes on safety of ‘Quick Start’ 
initiation of LARC for adolescents among a national sample of both public-sector providers 
and office-based physicians and highlight some areas for trainings and interventions. 
Addressing provider concerns regarding LARC safety is critical, given the evidence on the 
influence of provider perceptions and counseling on patient decision making.31 Unnecessary 
repeat visits can yield significant consequences for contraceptive access, particularly for 
vulnerable populations, including adolescents. Delaying insertion of LARC may result in 
decreased motivation and uptake of contraception, increasing the risk of an unintended 
pregnancy.32
Conclusions
Although the practice of ‘Quick Start’ of LARC for those who are medically eligible and the 
safety of LARC for adolescents is supported by US family planning guidance and 
professional organizations, only two-thirds of providers reported that they consider ‘Quick 
Start’ of LARC safe for adolescents. Targeted education, LARC insertion and removal 
training, and dissemination of US family planning guidance to health care providers, 
program managers, and policy makers in public-sector clinics and private physician offices 
may increase access to ‘Quick Start’ of LARC for adolescents.
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Table 1.
Sample Characteristics, US Health Care Providers Providing Family Planning Services
Public-Sector Providersc (n = 1,650) Office-Based Physicians (n = 406)
n
a %a,b n
a
%
a,b
Characteristics
Title X funding
Yes 1,052 52.5 - -
No 598 47.5 - -
Primary clinical focusd
Reproductive health 968 54.8 - -
Primary care 673 44.6 - -
Provider occupation
Physician 336 24.3 402 100.0
Advanced clinical practitionere 1,008 59.8 - -
Nurse 278 14.1 - -
Provider specialty
Obstetrics and gynecology - - 265 60.6
Family medicine - - 62 39.0
Adolescent medicine - - 79 0.34
Gender
Male 143 10.3 173 43.0
Female 1,496 89.1 232 56.4
Region
Northeast 224 14.3 79 15.8
Midwest 305 18.8 86 24.2
South/Mid-Atlantic 660 37.2 137 33.6
West 461 29.7 104 26.4
Trained in implant insertion
Yes 853 50.9 228 50.6
No 721 44.3 165 45.5
Trained in LNG-IUD or Cu-IUD insertion
Yes 1,025 62.6 312 85.2
No 583 34.7 88 13.5
Proportion of female patients of reproductive age who 
receive family planning servicesf
1–24% 165 11.9 59 19.5
25–49% 264 17.8 107 26.6
≥50% 1,192 68.4 237 52.4
Attitudes on the safety of ‘Quick Start’g initiation of 
contraceptive implant for adolescents
Safe 1,099 66.2 304 71.6
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Public-Sector Providersc (n = 1,650) Office-Based Physicians (n = 406)
n
a %a,b n
a
%
a,b
Characteristics
Unsafe or Don’t Know 470 28.8 94 26.5
Attitudes on the safety of ‘Quick Start’ initiation of IUDs 
for adolescents
Safe 1,043 62.9 275 64.7
Unsafe or Don’t Know 525 32.0 123 33.3
Cu-IUD, copper intrauterine device; LNG-IUD, levonorgestrel intrauterine device.
aUnweighted frequencies and weighted column percentages displayed.
bColumn percentages may not add to 100% due to missing data.
c
Includes Title-X and non-Title X providers.
d
Primary clinical focus at the clinic (reproductive health [obstetrics/gynecology or family planning/reproductive health] or primary care [family 
medicine, adolescent health or pediatrics, or general health care]).
e
Includes physician assistant, nurse practitioner, certified nurse midwife.
f
Family planning service is defined as any service related to postponing or preventing pregnancy. This may include a medical examination related 
to provision of a method, contraceptive counseling, method prescription, or supply visits. A patient may receive a family planning service even if 
the primary purpose of the visit is not for contraception.
g
‘Quick Start’ is defined as the immediate provision of contraception on the day of a woman’s visit, if reasonably certain she is not pregnant.
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